iPSC Array Fabrication via Micro Embossing and Acoustic Dispensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Creating viable large arrays of induced pluripotent stem cells (iPSCs) for high throughput drug screening is challenging due to their sensitivity to environmental factors, handling, and the need for precise dispensing of nano-liter quantities of molecules, which existing technologies struggle to address effectively.

Innovation Solution

A micro embossing fabrication process combined with a nano-liter dispensing system is used to create arrays of iPSCs in a defined micro-geometric pattern, allowing for the precise delivery of drug compounds to individual locations within the array, enhancing cellular growth and viability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If viruses are used to introduce reprogramming factors into adult cells, then iPSCs can be generated, but there is a risk of causing cancers

Engineering Contradiction:
Improvesafety of iPSC generationVSAvoidcancer risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the viral delivery component from the iPSC generation process. Instead of using viruses to deliver reprogramming factors, the invention uses direct transfection methods with plasmids or other non-viral vectors, thereby eliminating the carcinogenic risk while maintaining the ability to generate iPSCs

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces non-viral intermediaries (such as plasmids, liposomes, or electroporation buffers) as mediators to deliver reprogramming factors into adult cells. These intermediaries serve as safe alternatives to viruses, enabling genetic material delivery without the associated cancer risk

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If large arrays of iPSCs are created for high throughput drug screening, then drug screening capability is improved, but cell sensitivity to environmental factors and handling makes fabrication difficult

Engineering Contradiction:
Improvedrug screening throughputVSAvoidfabrication difficulty
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent segments the iPSC array fabrication process into discrete, controllable steps: cell seeding in defined geometric patterns, controlled environmental incubation, and systematic compound dispensing. This segmentation allows each step to be optimized independently, making large-scale array fabrication manageable despite cell sensitivity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent systematically controls and adjusts environmental parameters (temperature, CO2 levels, humidity, nutrient concentration) during fabrication and incubation. By precisely managing these parameters, the method maintains high cell viability while enabling large-scale array production for high throughput screening

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If precise dispensing of nano liter quantities of compounds is implemented, then drug screening accuracy is improved, but equipment complexity increases

Engineering Contradiction:
Improvecompound dispensing precisionVSAvoidequipment complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical dispensing systems with acoustically-driven liquid handling technology. Acoustic waves generate precise droplet formation and transport without requiring complex mechanical pumps or valves, achieving nano-liter precision while reducing overall system complexity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs self-aligning and self-regulating dispensing mechanisms where the acoustic field automatically positions droplets at correct locations based on the array geometry. The system self-corrects for minor positioning variations, reducing the need for complex feedback control mechanisms

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the creation of large arrays of iPSCs for high throughput drug screening by ensuring precise delivery of nano-liter quantities of compounds, improving cellular metabolism testing and drug efficacy assessment.

Implementation Method 1

exposed to UV radiation to harden the gel

Methodology Applied
Scientific EffectUV curing: Photopolymerisation

Data Source

PatentUS10625234B2Method of fabricating cell arrays and uses thereof
Publication Date: 2020.04.21 AXOSIM INC
  • US10625234B2 patent drawing

AI summary

The present disclosure provides a fabrication process that results in creating large arrays of living cells, such as stem cells, which are subsequently exposed to nanoliter quantities of compounds to test the efficacy on cellular metabolism.